AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HT942525C0004LUNA LABS USA LLC
Overview
Award facts
- Net obligations
- $1.30M
- $1,299,999of $1.30M potential value
- Period of performance
- Feb 5, 2025 to Jun 4, 2027
- Ends in 6 months
- Modifications
- 4
- Latest action Jul 14, 2026
- Contract type
- Definitive contract
- PIID HT942525C0004
Description of requirement
DHA STTR PHASE II PROPOSAL H2-0804, TITLED "SHELF-STABLE ANTIBIOTIC HYBRID EXOSOMES FOR THE TOPICAL TREATMENT OF WOUND INFECTIONS", MEDICAL R&D CONTRACT.
Dates and value
- Award date
- Signed on Feb 5, 2025
- Current value
- $1,299,999Base and exercised options
- Potential value (if all options are exercised)
- $1,299,999
Obligations by fiscal year of action
- FY2025: $1,299,999
Total across 1 fiscal year: $1,299,999
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 12, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 14, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationCHARLOTTESVILLE, VA
UEIM6JVSYRQRYM9
CAGE code8JML8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLUNA INNOVATIONS INCORPORATED
Business types and certifications
For-profit organizationLimited liability companyCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Agency and place
Awarding and funding
- Funded by
- Department of Defense
- Defense Health Agency
- HQ MRDC - MM
- Funded from
- Rdt&eProgram activities097-0130Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Charlottesville, Charlottesville City, Virginia 22903-5231
- Congressional district (place of performance)
- VA-05As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 4
Solicitation and notices
- Solicitation ID
- HQ003420RBDST(as reported)
- Solicitation date
- Aug 8, 2024
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Transaction history
Modification history
- Base award
- Feb 5, 2025Base obligation at award: $1,299,999
- Latest action
- Jul 14, 2026 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Jun 30, 2026 — Supplemental agreement (within scope)Modification P00003
- Actions by type
- Base award1
- Supplemental agreement (within scope)2
- Other administrative action2
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small technology transfer research program phase iiST2
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- Awarding agency code
- 9700
- Awarding sub-tier code
- 97DH
- Contracting office code
- HT9427
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97DH
- Funding office code
- HT0957
- Treasury accounts
- 097-2024/2025-0130-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression